3.325USD-8.65%Mkt Cap: 11.67M USDP/E: —Last update: 2026-05-26
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develo…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap11.67M USD
Enterprise Value8.67M USD
Revenue (TTM)852.28K USD
Gross Profit-17.27M USD
Net Income (TTM)-21.46M USD
Revenue/Share0.6360 USD
Last Price3.325 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees19
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.20
PEG—
EV/EBITDA-0.41
EV/Revenue10.18
P/S11.21
P/B15.71
EPS (TTM)-13.82
EPS (Forward)-0.86
52W Range
0.96307% of range34.75
52W High34.75 USD
52W Low0.9630 USD
Profitability
Gross Margin0.00%
Oper. Margin-2523.43%
EBITDA Margin0.00%
Profit Margin-862.34%
ROE-561.15%
ROA-338.46%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.47M USD
CapEx (TTM)27.61K USD
FCF Margin-1302.45%
FCF Yield-95.12%
Net Debt-877.19K USD
Net Debt/EBITDA0.04
Balance Sheet
Debt/Equity0.22
Current Ratio1.06
Quick Ratio0.56
Book Value/Sh0.1750 USD
Cash/Share0.3660 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateSep 25, 2020
Splits
Last Split1:25
Split DateJan 12, 2026
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)77.50 USD
Target Range10.00 USD – 212.50 USD
# Analysts3
Ownership
Shares Out.3.47M
Float3.47M
Insiders0.10%
Institutions9.85%
Short Interest
Short Ratio2.5d
Short % Float8.80%
Short % Out.8.79%
Shares Short254.32K
Short (prev mo.)252.98K
Technical
SMA 501.427 (+133.0%)
SMA 2007.913 (-58.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)9.77M
Avg Vol (10d)23.30M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—